ArticleCureus2025
Association Between Vitamin D Levels and Hypertensive Disorders of Pregnancy.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction Hypertension is a relatively common complication during pregnancy, and preeclampsia represents an important subset of these cases. It is linked to severe complications and adverse outcomes for both mother and baby. Vitamin D, crucial for bone metabolism and immune function, may impact placental function and preeclampsia risk. In Asia, including India, vitamin D deficiency is prevalent among pregnant women, raising questions about its role in hypertensive disorders of pregnancy. Materials and methods This cross-sectional study was conducted at Shaheed Hasan Khan Mewati Government Medical College, Nuh, Haryana, India, involving 300 pregnant women divided into hypertensive cases (150) and normotensive controls (150). Cases were further categorized into preeclampsia without severe features, preeclampsia with severe features, and the eclampsia group. Vitamin D levels were measured using the competitive enzyme-linked immunosorbent assay (ELISA) technique. Statistical analysis was performed using IBM SPSS Statistics software, version 26 (IBM Corp., Armonk, NY). Results The study found significant differences in mean vitamin D levels among the groups (p = 0.0001). Eclampsia had the lowest mean vitamin D level (8.73 ± 5.10 ng/mL), followed by preeclampsia with severe features (12.54 ± 7.12 ng/mL) and preeclampsia without severe features (13.70 ± 10.86 ng/mL), with controls having the highest level (21.41 ± 5.98 ng/mL). A significant negative correlation (r = -0.6159, p < 0.0001) was observed between the severity of hypertensive disorders and vitamin D levels. Conclusion Lower vitamin D levels are significantly associated with increased severity of hypertensive disorders of pregnancy. The findings suggest a potential role for vitamin D in mitigating these complications. Regular monitoring and potential supplementation may improve maternal and fetal outcomes. Further research is needed to confirm these findings and evaluate the effectiveness of vitamin D interventions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.